Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Universe Pharmaceuticals ( (UPC) ) just unveiled an announcement.
On September 2, 2025, Universe Pharmaceuticals INC held its reconvened annual general meeting of shareholders after an initial meeting on August 26, 2025, was adjourned due to a lack of quorum. During the meeting, shareholders approved all proposals, including the re-election of directors and a significant capital reduction plan. The capital reduction involves reducing the par value of shares and altering the company’s share capital structure, which is expected to provide greater financial flexibility and potentially improve shareholder value.
The most recent analyst rating on (UPC) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Universe Pharmaceuticals stock, see the UPC Stock Forecast page.
Spark’s Take on UPC Stock
According to Spark, TipRanks’ AI Analyst, UPC is a Neutral.
Universe Pharmaceuticals’ overall stock score is primarily impacted by its financial performance and technical analysis. The company’s financial difficulties, including declining revenues and profitability issues, are significant concerns. Technical indicators suggest bearish momentum, and valuation metrics are poor due to negative earnings.
To see Spark’s full report on UPC stock, click here.
More about Universe Pharmaceuticals
Universe Pharmaceuticals INC operates in the pharmaceutical industry, focusing on the development and distribution of traditional Chinese medicine products. The company is based in Ji’an, Jiangxi, China, and is involved in the production of a variety of pharmaceutical products aimed at addressing common health issues.
Average Trading Volume: 60,221
Technical Sentiment Signal: Sell
Current Market Cap: $2M
For an in-depth examination of UPC stock, go to TipRanks’ Overview page.